MIAMI, Jan. 08, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 42nd Annual J.P. Morgan Healthcare Conference, being held January 8-11, 2024 at Westin St. Francis hotel in San Francisco. …
Multiple data catalysts across all clinical programs expected throughout 2024, including data for WVE-006 in AATD which would provide first-ever RNA editing proof-of-mechanism in humans Selection of clinical candidate for GalNAc-siRNA INHBE program in …
News Highlights: Experience your newest personalized companion with HP Spectre x360 laptops, the world’s most adaptive PCs with built-in AI technology,1 the world’s most advanced convertible PCs for collaboration,2 and the world’s largest haptic touchpad …
ORANGE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that its Alignment Health Plan membership has increased by 44% to a total of approximately 155,500 members as of Jan. 1, following a successful …
News Highlights: HP’s most personalized gaming laptop yet, the OMEN Transcend 14 Gaming Laptop PC, delivers unparalleled portability to gamers and creators with exceptional performance, local and cloud-based AI solutions, and stunning customizable visuals. …
Completion of Patient Enrollment in XEN1101 Phase 3 X-TOLE2 Clinical Trial in Focal Onset Seizures Anticipated in Second Half of 2024 XEN1101 Phase 3 Program in Major Depressive Disorder Planned for Initiation in 2024 VANCOUVER, British Columbia, Jan. 08, …
HOLIDAY ISLAND, Ark., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Holiday Island Holdings, Inc. (OTC Pink: HIHI) – operating in the Secondary Recovery of Oil & Gas Industry – released the news today that it is changing its name to EP3 (Enhanced Petroleum …
PHILADELPHIA, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Shareholder protection law firm Kaskela Law LLC announces that it is investigating Axon Enterprise, Inc. (NASDAQ: AXON) (“Axon”) on behalf of the company’s long-term investors. On August 30, 2023, Reuters …
Dr. Adi Hoess to step down as CEO and Management Board Member Dr. Andreas Harstrick appointed Interim CEO Strategic restructuring reducing headcount by up to 50%, extending cash runway into H2 2025 Go forward organization will focus on advancing clinical …
Leading Investors BOLD Capital, Digitalis Ventures, and Hill Creek Partners drive financial milestone Financing to expedite conditional FDA approval of lead candidate and derisk therapeutic platform for accelerated market access SAN DIEGO, Jan. 08, 2024 ( …
Company achieved significant commercial progress in 2023 IBSRELA® now expected to generate greater than $1.0 billion in annual U.S. net product sales revenue at peak Webcast scheduled for 7:00 PM ET / 4:00 PM PT to discuss IBS-C Market WALTHAM, Mass., Jan. …
Partnership aims to include Aclarion’s surgical decision support technology within ATEC’s AlphaInformatiX platform to better inform spine surgery Aclarion’s Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar …
Complete enrollment in Denali-led, late-stage programs for MPS II and ALS, and establish commercial readiness Advance broad clinical-stage portfolio of seven therapeutic product candidates across neurodegeneration (ALS, Parkinson’s disease, MS, FTD-GRN), …
Succeeds Marc Eisenberg, who will serve as Executive Chairman of the Company’s Board of Directors ROCHELLE PARK, N.J., Jan. 08, 2024 (GLOBE NEWSWIRE) -- ORBCOMM Inc. (“ORBCOMM” or the “Company”), a leading global provider of supply chain IoT technology, …
Combined organizations have helped more than 1 million kids Expands Specialty Bracing Division with pediatric orthotic management business offering leading technology and pediatric care through dedicated clinics Closes $80 million debt financing to support …
Rockville, Jan. 08, 2024 (GLOBE NEWSWIRE) -- As per Fact.MR, a provider of market research and competitive intelligence, the global Tea Concentrate Market is valued at US$ 1,512.5 million in 2024 and is projected to expand steadily at a 4.6% CAGR through …
Positive preliminary analysis of 15 mg cohort in the PRAX-628 study in epilepsy patients with Photo-Paroxysmal Response (PPR) exceeds expectations; topline results expected in 1Q 2024 after completion of 45 mg cohort Enrollment for both ulixacaltamide …
PLEASANTON, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, welcomes the adoption of UnitedHealthcare’s updated medical policy (#2024T0525NN) for …
LOS ANGELES, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Dave’s Hot Chicken has gone from scrappy, late-night pop-up to become the fastest growing restaurant chain in the nation. Starting January 8, the brand will be hand seasoning and frying up its first new core …
Beijing, Jan. 08, 2024 (GLOBE NEWSWIRE) -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that the probability of …
05 days 10:00:40
